Important message for customers


In the coming months Life Letters will be launching our new clinic and novel technology to help artfully re-shape healthcare in this country and beyond. This technology will dramatically change the experience for patients within the primary healthcare setting and our engineering and medical teams have been diligently breathing life into this vision.

With primary care now our focus we have made the difficult decision to cease the Tiny Letters preconception carrier screening test. Whilst we still strongly believe in the benefits of preconception carrier screening, genetics will be revisited in a new format in the future.

In the meantime, our genetic counsellors will continue working hard to provide any assistance you may need. For patients with results still pending, our staff will contact you to book a result delivery appointment once your reports become available. For those with testing complete, please note that your Tiny Letters reports will be available online until September 30th, 2016.

If you have any further questions, please contact us at [email protected] or call us on 1300 538 837.

Life Letters is an Australian genetics company wanting to responsibly bring genetic testing to the general public. We believe that through genetics people can gain a greater understanding of their own bodies and make informed decisions about their health and the health of their families.

No ulterior motives

We sell our tests at a reasonable price so we don't need to subsidise the test through other means. In other words, we will never distribute or sell your data, at least not without your explicit consent.

Seek guidance and opinions

We appreciate that genetics raises a lot of ethical, legal and emotional questions. To help us deliver this form of testing in a responsible manner, we have put together an advisory board with some of the most influential minds in healthcare, science and genetics.

Well recognised science

We only offer tests that are based on independent, evidence based research recognised by leading bodies, such as The Clinical Pharmacogenetics Implementation Consortium.